限水减少经蝶手术后迟发性低钠血症及再入院
该研究通过两项回顾性分析和一项前瞻性研究,评估三种策略对经蝶手术患者术后低钠血症及再入院率的影响。结果显示,出院时限水1 L/d可减少迟发性低钠血症和再入院约50%;标准化患者教育和术后第7天血钠检测可降低低钠血症严重程度但不影响再入院率。
要点
- 出院时限水1 L/d使迟发性低钠血症减少约2倍(12.7%,RR=0.52),再入院减少约3倍(4.6%,RR=0.30)。
- 术后第7天血钠检测联合患者教育使低钠血症严重程度降低60%,但再入院率未变。
- 因低钠血症再入院使费用增加30%。
核心结论
- 出院时限水1 L/d使迟发性低钠血症和再入院率降低约50%。
- 标准化患者教育和术后第7天血钠检测降低低钠血症严重程度但不影响再入院率。
- 作者认为这些方案应被视为经蝶手术患者的标准实践。
研究设计与样本
- 两项回顾性分析和一项前瞻性研究,分为三个阶段:第1阶段无干预,第2阶段术后第7天血钠检测和患者教育,第3阶段在第2阶段基础上出院时限水1 L/d。
- 研究在三级转诊医院进行,对象为因垂体腺瘤及其他鞍区和鞍旁病变接受经蝶手术的患者。
- 第1阶段296例,第2阶段316例,第3阶段110例。
主要发现
- 第1阶段:20%发生早期低钠血症,28%发生迟发性低钠血症;38%接受术后第7天血钠检测;总再入院率15%,低钠血症再入院率4.3%。
- 第2阶段:22%发生早期低钠血症,25%发生迟发性低钠血症;89%遵守术后第7天血钠检测;再入院率未变,但低钠血症严重程度降低60%。
- 第3阶段:迟发性低钠血症减少2倍(12.7%,相对风险RR=0.52),再入院减少3倍(4.6%,RR=0.30(0.12-0.73));因低钠血症再入院显著减少。
- 因低钠血症再入院使费用增加30%。
关键数值与推荐
- 第3阶段出院时限水1 L/d使迟发性低钠血症发生率为12.7%,相对风险RR=0.52。
- 第2阶段低钠血症严重程度降低60%。
临床怎么用
- 作者认为出院时限水1 L/d、标准化患者教育和术后第7天血钠检测的方案应被视为经蝶手术患者的标准实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Postoperative hyponatremia leads to prolonged hospital length of stay and readmission within 30 days. OBJECTIVE: To assess 3 strategies for reducing rates of postoperative hyponatremia and analyze risk factors for hyponatremia. DESIGN: Two retrospective analyses and 1 prospective study. SETTING: Tertiary referral hospital. PATIENTS: Patients undergoing transsphenoidal surgery for pituitary adenomas and other sellar and parasellar pathologies. INTERVENTION(S): Phase 1: no intervention. Phase 2: postoperative day (POD) 7 sodium testing and patient education. Phase 3: fluid restriction to 1 L/day on discharge in addition to phase 2 interventions. MAIN OUTCOME MEASURES: Rates of early and delayed hyponatremia and readmissions. Secondary outcomes were risk factors for hyponatremia and readmission costs. RESULTS: In phase 1, 296 patients underwent transsphenoidal surgery. Twenty percent developed early and 28% delayed hyponatremia. Thirty-eight percent underwent POD 7 sodium testing. Readmission rates were 15% overall and 4.3% for hyponatremia. In phase 2 (n = 316), 22% developed early and 25% delayed hyponatremia. Eighty-nine percent complied with POD 7 sodium testing. Readmissions were unchanged although severity of hyponatremia was reduced by 60%. In phase 3 (n = 110), delayed hyponatremia was reduced 2-fold [12.7%, relative risk (RR) = 0.52] and readmissions 3-fold [4.6%, RR = 0.30 (0.12-0.73)]; readmissions for hyponatremia were markedly reduced. Hyponatremia readmission increased costs by 30%. CONCLUSIONS: Restricting fluid to 1 L/day on discharge decreases rates of delayed hyponatremia and readmissions by 50%. Standardized patient education and POD 7 sodium testing decreases severity of hyponatremia but does not impact readmission rates. These protocols should be considered standard practice for patients undergoing transsphenoidal surgery.
引用
- Cooper O, Lis R, Bonert V, et al. Fluid Restriction Reduces Delayed Hyponatremia and Hospital Readmissions After Transsphenoidal Surgery. J Clin Endocrinol Metab. 2023. PMID: 36723998. doi:10.1210/clinem/dgad066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。